Strengthening Mosquito Abatement for Safety and Health Act or the SMASH Act
This bill amends the Public Health Service Act to revise and extend through FY2021 Centers for Disease Control and Prevention (CDC) grants for mosquito control programs. The grant program is expanded so that grants may be used to address emerging, infectious mosquito-borne diseases and to improve existing control programs. The CDC must give preference to applicants that have: (1) a public health emergency due to a mosquito-borne disease, or (2) a control program that is consistent with existing state preparedness plans. The requirement for matching funds may be waived if the area covered by a grant applicant has an extreme need due to the size or density of the human population, the size or density of the mosquito population, or the severity of the mosquito-borne disease.
[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5492 Introduced in House (IH)]
<DOC>
114th CONGRESS
2d Session
H. R. 5492
To support programs for mosquito-borne and other vector-borne disease
surveillance and control.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 15, 2016
Mr. Murphy of Florida (for himself and Mr. Clawson of Florida)
introduced the following bill; which was referred to the Committee on
Energy and Commerce
_______________________________________________________________________
A BILL
To support programs for mosquito-borne and other vector-borne disease
surveillance and control.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Strengthening Mosquito Abatement for
Safety and Health Act'' or the ``SMASH Act''.
SEC. 2. REAUTHORIZATION OF MOSQUITO ABATEMENT FOR SAFETY AND HEALTH
PROGRAM.
Section 317S of the Public Health Service Act (42 U.S.C. 247b-21)
is amended--
(1) in subsection (a)(1)(B)--
(A) by inserting ``including programs to address
emerging infectious mosquito-borne diseases,'' after
``control programs,''; and
(B) by inserting ``or improving existing control
programs'' before the period at the end;
(2) in subsection (b)--
(A) in paragraph (1), by inserting ``, including
improvement,'' after ``operation'';
(B) in paragraph (2)--
(i) in subparagraph (A)--
(I) in clause (ii), by striking
``or'' at the end;
(II) in clause (iii), by striking
the semicolon at the end and inserting
``, including an emerging infectious
mosquito-borne disease that presents a
serious public health threat; or''; and
(III) by adding at the end the
following:
``(iv) a public health emergency due to the
incidence or prevalence of a mosquito-borne
disease that presents a serious public health
threat.''; and
(ii) in subparagraph (D), by inserting ``or
that demonstrates to the Secretary that the
control program is consistent with existing
State mosquito control plans, or policies, or
other applicable State preparedness plans''
before the period at the end;
(C) in paragraph (4)(C), by striking ``that
extraordinary'' and all that follows through the period
at the end and inserting ``that--
``(i) extraordinary economic conditions in
the political subdivision or consortium of
political subdivisions involved justify the
waiver; or
``(ii) the geographical area covered by a
political subdivision or consortium for a grant
under paragraph (1) has an extreme need due
to--
``(I) the size or density of the
human population;
``(II) the size or density of the
mosquito population; or
``(III) the severity of the
mosquito-borne disease, such that
expected serious adverse health
outcomes for the human population
justify the waiver.''; and
(D) by amending paragraph (6) to read as follows:
``(6) Number of grants.--A political subdivision or a
consortium of political subdivisions may not receive more than
one grant under paragraph (1).''; and
(3) in subsection (f)--
(A) in paragraph (1), by striking ``$100,000,000
for fiscal year 2003, and such sums as may be necessary
for each of fiscal years 2004 through 2007'' and
inserting ``$130,000,000 for each of fiscal years 2016
through 2021'';
(B) in paragraph (2), by striking ``the Public
Health Security and Bioterrorism Preparedness and
Response Act of 2002'' and inserting ``other medical
and public health preparedness and response laws''; and
(C) in paragraph (3)--
(i) in the heading, by striking ``2004''
and inserting ``2017''; and
(ii) by striking ``2004'' and inserting
``2017''.
SEC. 3. EPIDEMIOLOGY-LABORATORY CAPACITY GRANTS.
Section 2821 of the Public Health Service Act (42 U.S.C. 300hh-31)
is amended--
(1) in subsection (a)(1), by inserting ``, including
mosquito and other vector-borne diseases,'' after ``infectious
diseases''; and
(2) in subsection (b), by striking ``2010 through 2013''
and inserting ``2016 through 2021''.
SEC. 4. GAO STUDY.
(a) Study.--The Comptroller General of the United States shall
conduct a study on the state of surveillance and control of mosquito-
borne infectious diseases in the United States and territories,
including the state of preparedness for conducting such surveillance
and control. The study shall include--
(1) a description of the infrastructure and programs for
mosquito control in the United States, including--
(A) how such infrastructure and programs are
organized and implemented at the Federal, State and
local levels, including with respect to departments and
agencies of the States, and local organizations
(including special districts) involved in such control
programs;
(B) the role of the private sector in such
activities;
(C) how the authority for mosquito control impacts
such activities; and
(D) the resources for such infrastructure and
programs, including Federal, State, and local funding
sources;
(2) how mosquito and other vector-borne disease
surveillance and control is integrated into Federal, State, and
local preparedness plans and actions, including how zoonotic
surveillance is integrated into infectious disease surveillance
to support real-time situational surveillance and awareness;
(3) Federal, State, and local laboratory capacity for
emerging vector-borne diseases, including mosquito-borne and
other zoonotic diseases; and
(4) any regulatory challenges for developing and utilizing
vector-control technologies and platforms as part of mosquito
control strategies.
(b) Consultations.--In conducting the study under subsection (a),
the Comptroller General of the United States shall consult with--
(1) State and local public health officials involved in
mosquito and other vector-borne disease surveillance and
control efforts;
(2) researchers and manufacturers of mosquito control
products;
(3) stakeholders involved in mosquito abatement activities;
(4) infectious disease experts; and
(5) entomologists involved in mosquito-borne disease
surveillance and control efforts.
(c) Report.--Not later than 18 months after the date of enactment
of this Act, the Comptroller General of the United States shall submit
to the Committee on Health, Education, Labor, and Pensions of the
Senate and the Committee on Energy and Commerce of the House of
Representatives a report containing the results of the study conducted
under subsection (a) and relevant recommendations for Zika virus and
other mosquito-borne diseases preparedness and response efforts.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line